* Indications: Management of hypocalcaemia, and osteodystrophy in patients with chronic renal failure.
& & – Renal Bone Disease: Most patients with osteitis fibrosa and osteomalacia show a symptomatic && gradual biochemical,
& & radiographic and histological improvement.
& & – Hypoparathgroidism: Low plasm calcium levels are restored to normal relatively quickly with Bone Care. Severe hypocalcaemia
& & (e.g after extensive neck surgery) may decline with higher doses of Bone Care (e.g 3-5 micrograms) and calcium supplements.
& & Normocalcaemia may be maintained with smaller doses within a relatively narrow dose range.
& & – Secondary Hyperparathyroidism: Following parathyroidectomy, patients with primary or tertiary hyperparathyroidism && bone
& & disease often require large doses of vitamin D && intravenous calcium to avoid severe hypocalcaemia. Preliminary studies
& & suggest that pre-operative treatment with Bone Care for 2 to 3 weeks alleviates bone pain && myopathy when present without
& & aggravating pre-operative hypercalcaemia. Continued post-operative treatment decreases post-operative hypocalcaemia
& & and should be continued until the plasma alkaline phosphatase level falls to normal or hypercalcaemia occurs.
& & – Hypophosphataemic Vitamin D resistant rickets and osteomalacia: This is characterized by phosphataemia due to detective
& & renal tubular reabsorption of phosphorus. Neither large doses of vitamin D nor phosphate supplements are entirely satisfactory,
& & the latter tending to produce hypocalcaemia && hyperparathyroidism. Bone Care relieves myopathy when present, increases
& & caclium && phosphorus retention && promotes done healing. Phosphate supplements may also be required in some patients.
& & – Pseudo-deficiency (D-dependent) rickets: This requires large doses of vitamin D probably because of an inherited defect
& & in the production of 1,25-(OH)2D3 Bone Care reverses this condition.
& & – Nutritional && malabsorptive rickets && osteomalacia: Nutritional rickets && osteomalacia can be cured with physiological doses of
& & Bone Care. Patients with malabsorptive osteomalacia responding to large doses of vitamin D will respond to small doses of
& & Bone Care.
* Dosage && administration:
& & – Adults: 1 microgram daily.
& & – Children over 20 Kg body mass: 1 microgram daily.
& & – Children under 20 Kg body mass: 0.05 micrograms/KG daily.
* Keep at room temperature, between 15 degrees C && 25 degrees C. Protect from direct sunlight && heat.
* Produced by: Arab Company for Gelatin && Pharmaceutical Products, for: Multicare Egypt for Pharmaceutical Industries, for: Pharmacare.
Weight | 100 kg |
---|
Add a review
You must be logged in to post a review
Log In
Q & A
There are no questions yet
Ask a question
Your question will be answered by a store representative or other customers.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Thank you for the question!
Your question has been received and will be answered soon. Please do not submit the same question again.
Error
An error occurred when saving your question. Please report it to the website administrator. Additional information:
Add an answer
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Thank you for the answer!
Your answer has been received and will be published soon. Please do not submit the same answer again.
Error
An error occurred when saving your answer. Please report it to the website administrator. Additional information:
2 reviews for BONE CARE 0.5 MCG 30 CAP